Kell leverages 20 years of leadership at some of the world’s largest pharmaceutical companies along with a decade of healthcare consulting experience to help clients achieve regulatory success and communicate product value. He has been instrumental in developing 3D Communications’ processes, tools, and training to help clients prepare for regulatory submissions, key regulatory meetings at FDA and EMA, and important meetings with payers.
Kell collaborates with clients to systematically identify the strengths and weaknesses in their data, consider the realities of their environment, and develop compelling messages that help companies differentiate their products. His knowledge and broad experience in regulatory affairs, science, marketing, and value communications provide the unique holistic approach that is essential in today’s competitive market.
Kell has held US and international leadership positions at Roche, Novartis, Ciba, and Merck in clinical development and trial strategy, branding and positioning, advocacy development, commercialization, and payer strategy. He holds an MBA and a BS in microbiology from Penn State University.
Kell is an avid sports enthusiast, with a special interest in European football leagues, and enjoys traveling with his wife and family.